Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-17

FDA Approved: CAPECITABINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Capecitabine filed by Sun Pharmaceutical Industries, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capecitabine (capecitabine)

Snippet

SUPPL AP for CAPECITABINE (CAPECITABINE)